Fig. 4
From: A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
Expression plot of ELISA-detected OD values for 15 TAAbs in the test set. Comparison between PDAC, NC, and BPD samples (ns: P > 0.05, *: P < = 0.05, **: P < = 0.01, ***: P < = 0.001, ****: P < = 0.0001); PDAC: pancreatic ductal adenocarcinoma, NC: normal control, BPD: benign pancreatic diseases